Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,284,118
-$93,463 QoQ
Shares Held
5,103
-19.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#2,319
of 4,153 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EARNED WEALTH ADVISORS, LLC holds $8,347,145 across 10 Drug Manufacturers - General names. ABBV ranks #3 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,314 | $2,775,481 | |
| 2 | JNJ |
Johnson & Johnson
|
6,284 | $1,595,947 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
5,103 | $1,284,118 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
7,324 | $925,314 | |
| 5 | MRK |
Merck & Co., Inc.
|
3,294 | $423,279 | |
| 6 | PFE |
Pfizer Inc
|
15,837 | $381,354 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,515 | $260,154 | |
| 8 | AZN |
Astrazeneca PLC
|
1,288 | $244,230 |
All Filings in ABBV
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,284,118 | 5,103 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,377,581 | 6,334 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,322,500 | 5,788 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $866,191 | 3,741 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $581,176 | 3,131 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $625,626 | 2,986 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $237,940 | 1,339 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $257,316 | 1,303 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $210,969 | 1,230 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $215,970 | 1,186 | Shares | Sole | 2024-04-26 | |
| No filing history on record for this holder in this stock. | ||||||